DNMT3B antibody (AA 258-472) (HRP)
Quick Overview for DNMT3B antibody (AA 258-472) (HRP) (ABIN7985802)
Target
See all DNMT3B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 258-472
-
Purpose
- Anti-DNMT3B Antibody HRP Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human DNMT3B recombinant protein (Position: M258-D472).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- DNMT3B (DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B))
-
Alternative Name
- DNMT3B
-
Background
-
Background: DNA (cytosine-5-)-methyltransferase 3 beta, is an enzyme that in humans in encoded by the DNMT3B gene. CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined.
Gene Full Name: DNA methyltransferase 3 beta
-
Gene ID
- 1789
-
UniProt
- Q9UBC3
Target
-